Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METRO: Early Discontinuation of Steroids in IRF
NCT05428826Phase 4Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2022
- Primary completion
- Nov 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisone in Idiopathic retroperitoneal fibrosis (RPF), sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2022; status: recruiting.
02
Drugs
prednisone
03
Conditions
Idiopathic retroperitoneal fibrosis (RPF)
Beyond the preview
Go deeper on NCT05428826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05428826.